BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.) Mr. Walbert led Horizon ... from its founding in 2008 to acquisition by Amgen in 2023. Mr. Walbert is currently senior ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Stocks to Consider. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other best pharma stocks to buy according to hedge funds. The US pharmaceutical sector is ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

In recent trading, shares of Amgen Inc (Symbol: AMGN) have crossed above the average analyst 12-month target price of $317.58, changing hands for $317.82/share. When a stock reaches the target an ...

Amgen’s dividend payout ratio is currently 126.09%. Amgen Inc discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to ...